Skip to content

Measuring the Electrical Properties of Malignant Tissues In Vivo

Measuring the Electrical Properties of the Malignant Tissues During Cancer Surgeries

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02747225
Enrollment
50
Registered
2016-04-21
Start date
2018-12-31
Completion date
2020-12-31
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

electrical properties, malignant tissues, in vivo

Brief summary

Previously published studies have indicated that there exist difference in electrical properties (EPs), i.e., the conductivity and relative permittivity, between malignant and adjacent normal tissue, which will be useful in the early detection of cancers. However the EP information mainly based on ex vivo measurement of cancer tissues, and few data in vivo were published. The purpose of this study is to in vivo measure the electrical properties of the malignant tissues.

Detailed description

The measurements were safety guaranteed and were conducted during the cancer surgeries. Before the tissue was excised from the patient,the pathologist assisted the operator (already at the operating room) responsible for the measurement.The measurement of malignant and corresponding normal tissues were both performed. The tissues for dielectric properties measurement were classified as normal or malignant by the pathologist based on his own expertise and decision criteria (visual inspection, anatomy) and the per-operative histological examination. The measurements were directly performed on the tissue before excision.The sites of the measured malignant tissues were marked,doubletracked according to the pathological report to make sure the marked sites are malignant. The patient age and tissue temperature at the time of measurement were recorded.

Interventions

The dielectric properties of the tissues were measured using the open-ended coaxial line method. The measurement system consisted of a network analyzer (Model 4395A, Agilent Corp., Santa Clara, CA) associated with an S-parameter test set (Model 87511A, Agilent Corp., Santa Clara, CA). A semi-rigid coaxial line with a diameter of 3.58 mm was connected to the network analyzer system by using a Bayonet Neill-Concelman connector. The other tip of the coaxial line (probe) was placed on the flat bare surface of the tissue.

Sponsors

Zhujiang Hospital
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
CollaboratorOTHER
Southern Medical University, China
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of cancer Disease

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Conductivity of the Malignant Tissues measured In Vivoone year
Relative Permittivity of the Malignant Tissues measured In Vivoone year

Countries

China

Contacts

Primary ContactSherman X Xin, professor
xxg@smu.edu.cn008613602733465

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026